ThedaCare has introduced a new image-guided laser technology, NeuroBlate laser therapy, to treat brain tumors and lesions. This makes ThedaCare the first health system in northeast and central Wisconsin to use this technology.
NeuroBlate uses real-time magnetic resonance imaging (MRI) to guide a controlled laser probe directly to abnormal tissue in the brain. This method allows surgeons to ablate targeted areas while reducing potential harm to surrounding healthy tissue.
ThedaCare treated its first patient with NeuroBlate in mid-January. Dr. Joseph Bovi, a Radiation Oncologist with ThedaCare Cancer Care, said, “This procedure may be a good alternative to treating a brain tumor or lesion through a large incision. For many patients, laser ablation may offer an important option when health status, age or tumor location makes traditional surgery too risky or when a less invasive approach is preferred.”
Froedtert & the Medical College of Wisconsin was the first organization in the state to use NeuroBlate technology. Support from ThedaCare Foundation-Neenah enabled ThedaCare’s acquisition of the equipment.
Barbara Beuscher, Senior Vice President and Chief Philanthropy Officer for ThedaCare Family of Foundations, said, “Transformative innovations like NeuroBlate are only made possible through the unwavering generosity of our donors. Their support is the catalyst that empowers ThedaCare to bring groundbreaking, life-changing technologies to our community, offering new hope to patients and families facing the most challenging diagnoses. We are profoundly grateful for their partnership in to improve the health and well-being of the communities we serve.”
Dr. Bovi explained that NeuroBlate can be used for newly diagnosed primary brain tumors as well as recurrent tumors, particularly those that are deep-seated or hard-to-reach.
The procedure requires only a small hole in the skull—about pencil-sized—rather than a large opening as with traditional surgery. During treatment, patients remain inside an MRI machine while an MRI-compatible robot positions the laser probe into place. Surgeons can then deliver energy precisely and monitor changes in temperature within brain tissue in real time.
Dr. Evan Krueger, neurosurgeon with Neuroscience Group who performs surgeries at ThedaCare, highlighted several advantages: “Patients who undergo laser ablation may experience a shorter hospital stay, lower risk of complication and hospital readmission rates,” he said. “For many, recovery may be faster, and patients may return more quickly to their daily activities.” He also noted there is potentially decreased risk of surgical site infections.
According to Dr. Bovi, providing this technology locally reduces travel burdens for patients who previously had to go elsewhere in Wisconsin for similar care. He said it helps keep patients close to their support systems and may improve overall recovery experiences by enabling both pre- and post-operative visits nearby.
